There are problems in the US healthcare system with slow adoption of clinical practice guidelines and lack of research funding for non-pharmaceutical treatments. But on an objective scientific basis the recent studies funded by pharma tend to be some of the highest quality work. They have huge budgets and are held to fairly high standards now by the FDA so we tend to see large subject populations, multiple sites, proper controls, and rigorous statistical analysis.